Szegedi G - Search Results

1

Antiprothrombin and antiannexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases.

Lakos G, Kiss E, Regeczy N, Tarjan P, Soltesz P, Zeher M, Bodolay E, Szucs G, Szakony S, Sipka S, Szegedi G. Lakos G, et al. Among authors: szegedi g. J Rheumatol. 2000 Apr;27(4):924-9. J Rheumatol. 2000. PMID: 10782817

2

Systemic lupus erythematosus survival in Hungary. Results from a single centre.

Kiss E, Regéczy N, Szegedi G. Kiss E, et al. Among authors: szegedi g. Clin Exp Rheumatol. 1999 Mar-Apr;17(2):171-7. Clin Exp Rheumatol. 1999. PMID: 10342042

3

Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype.

Lakos G, Kiss E, Regëczy N, Tarján P, Soltész P, Zeher M, Bodolay E, Szakony S, Sipka S, Szegedi G. Lakos G, et al. Among authors: szegedi g. Clin Exp Immunol. 1999 Sep;117(3):574-9. doi: 10.1046/j.1365-2249.1999.01007.x. Clin Exp Immunol. 1999. PMID: 10469065 Free PMC article.

4

Hypercoagulability in various autoimmune diseases: no association with factor V Leiden mutation.

Regéczy N, Balogh I, Lakos G, Zeher M, Bodolay E, Szücs G, Kiss E, Ajzner E, Szegedi G. Regéczy N, et al. Among authors: szegedi g. Haematologia (Budap). 2000;30(1):35-9. doi: 10.1163/15685590051129869. Haematologia (Budap). 2000. PMID: 10841323

5

Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD).

Bodolay E, Csiki Z, Szekanecz Z, Ben T, Kiss E, Zeher M, Szücs G, Dankó K, Szegedi G. Bodolay E, et al. Among authors: szegedi g. Clin Exp Rheumatol. 2003 May-Jun;21(3):313-20. Clin Exp Rheumatol. 2003. PMID: 12846049

6

No short-term immunological effects of Pneumococcus vaccination in patients with systemic lupus erythematosus.

Tarján P, Sipka S, Maródi L, Nemes E, Lakos G, Gyimesi E, Kiss E, Ujj G, Szegedi G. Tarján P, et al. Among authors: szegedi g. Scand J Rheumatol. 2002;31(4):211-5. doi: 10.1080/030097402320318396. Scand J Rheumatol. 2002. PMID: 12369652 Clinical Trial.

7

The Leiden mutation of coagulation factor V in Hungarian SLE patients.

Regéczy N, Lakos G, Balogh I, Ajzner E, Kiss E, Szegedi G. Regéczy N, et al. Among authors: szegedi g. Clin Appl Thromb Hemost. 2000 Jan;6(1):41-5. doi: 10.1177/107602960000600107. Clin Appl Thromb Hemost. 2000. PMID: 10726048 Free article.

8

Catastrophic antiphospholipid syndrome in cancer.

Soltész P, Szekanecz Z, Végh J, Lakos G, Tóth L, Szakáll S, Veres K, Szegedi G. Soltész P, et al. Among authors: szegedi g. Haematologia (Budap). 2000;30(4):303-11. doi: 10.1163/156855900300109549. Haematologia (Budap). 2000. PMID: 11204029

9

Decreased arachidonic acid release in peripheral blood monocytes of patients with systemic lupus erythematosus.

Sipka S, Szántó S, Szucs K, Kovács I, Kiss E, Antal-Szamás P, Lakos G, Aleksza M, Illés A, Gergely P, Szegedi G. Sipka S, et al. Among authors: szegedi g. J Rheumatol. 2001 Sep;28(9):2012-7. J Rheumatol. 2001. PMID: 11550968

10

[Significance of anti-nucleosome (anti-chromatin) auto-antibodies in systemic lupus erythematosus].

Kiss E, Lakos G, Németh J, Sipka S, Szegedi G. Kiss E, et al. Among authors: szegedi g. Orv Hetil. 2001 Aug 12;142(32):1731-6. Orv Hetil. 2001. PMID: 11570008 Hungarian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

446 results

Search Page

Filters